Detail Information of Xenobiotics
| General Information of Xenobiotics (ID: XEO02464) | ||||||
|---|---|---|---|---|---|---|
| Xenobiotics Name |
BMAP-27
|
|||||
| Xenobiotics Type |
Amino Acid(s), Peptide(s) or Protein(s)
|
|||||
| Classification |
Peptide
|
|||||
| Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=16130511"></iframe>
|
 |
||||
| 3D MOL | 2D MOL | |||||
| PubChem CID | ||||||
| DME(s) Modulated by This Xenobiotics | ||||||
| DME(s) Inhibited by This Xenobiotics | ||||||
| D-Lactate dehydrogenase (ldhA) | DME Info | Pseudomonas aeruginosa | [1] | |||
| Arylamine N-acetyltransferase (NAT) | DME Info | Pseudomonas aeruginosa | [1] | |||
| Hydroxybenzoate 3-monooxygenase (pobA) | DME Info | Pseudomonas aeruginosa | [1] | |||
| References | ||||||
| 1 | Antibacterial and anti-biofilm effects of cathelicidin peptides against pathogens isolated from cystic fibrosis patients. Peptides. 2011 Sep;32(9):1807-14. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.